Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Zentalis Pharmaceuticals (ZNTL) Leases (2022 - 2025)

Zentalis Pharmaceuticals has reported Leases over the past 4 years, most recently at $26.3 million for Q4 2025.

  • Quarterly results put Leases at $26.3 million for Q4 2025, down 19.24% from a year ago — trailing twelve months through Dec 2025 was $26.3 million (down 19.24% YoY), and the annual figure for FY2025 was $26.3 million, down 19.24%.
  • Leases for Q4 2025 was $26.3 million at Zentalis Pharmaceuticals, down from $30.2 million in the prior quarter.
  • Over the last five years, Leases for ZNTL hit a ceiling of $43.6 million in Q1 2022 and a floor of $26.3 million in Q4 2025.
  • Median Leases over the past 4 years was $35.3 million (2023), compared with a mean of $35.7 million.
  • Peak annual rise in Leases hit 6.87% in 2025, while the deepest fall reached 19.24% in 2025.
  • Zentalis Pharmaceuticals' Leases stood at $42.4 million in 2022, then decreased by 15.24% to $35.9 million in 2023, then decreased by 9.43% to $32.5 million in 2024, then fell by 19.24% to $26.3 million in 2025.
  • The last three reported values for Leases were $26.3 million (Q4 2025), $30.2 million (Q3 2025), and $31.2 million (Q2 2025) per Business Quant data.